aluates Reports

$ 0.0

Automative

Global Pharma and Health Care Market Research Report 2024

Published Date: March 2024

Report Code: QYRE-Auto-19L9258

Global Pharma and Health Care Market Insights and Forecast to 2028

BUY CHAPTERS

Global Pharma and Health Care Market Research Report 2024

Code: QYRE-Auto-19L9258

Report

March 2024

Pages:104

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Johnson & Johnson

Novartis

Roche

AbbVie

Merck

Bristol–Myers Squibb

GlaxoSmithKline PLC

Pfizer Inc

Sanofi

Takeda

Astrazeneca plc

Bayer

Eli Lilly & Co

Gilead Sciences

Amgen Inc

Novo Nordisk

TEVA

Boehringer Ingelheim

Biogen

Astellas

Pharma and Health Care Market Size

The global Pharma and Health Care market was valued at US$ 1245880 million in 2023 and is anticipated to reach US$ 1644850 million by 2030, witnessing a CAGR of 4.0% during the forecast period 2024-2030.

Pharma and Health Care Market

The pharmaceutical industry, it is composed of companies developing and manufacturing innovative medicines and generic pharmaceuticals, as well as over–the-counter drug products. The sector is made up of a number of sub-sectors that service different market segments.

Health products are vitamins, minerals, herbal medicines, homeopathic preparations, probiotics and even some traditional medicines are also prescribed by doctor or any equivalent physician.

In this report, we mainly study the pharma and healthcare product.

North America is the largest consumption place, with a consumption market share nearly 50%. Following North America, Asia-Pacific is the second largest consumption place with the consumption market share of 25%.

Market competition is intense. The key players are Johnson & Johnson, Novartis, Roche, AbbVie, Merck & Co., etc. The top five vendors held 20% of the market share.

This report aims to provide a comprehensive presentation of the global market for Pharma and Health Care, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharma and Health Care.

Report Scope

The Pharma and Health Care market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pharma and Health Care market comprehensively. Regional market sizes, concerning products by Format, by Prescription, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Pharma and Health Care companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Format, by Prescription, and by regions.

Market Segmentation

Scope of Pharma and Health Care Market Report

Report Metric	Details
Report Name	Pharma and Health Care Market
Accounted market size in 2023	US$ 1245880 million
Forecasted market size in 2030	US$ 1644850 million
CAGR	4.0%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Format	Bottle Blister Others
Segment by Prescription	OTC Drugs Prescription Drugs
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Johnson & Johnson, Novartis, Roche, AbbVie, Merck & Co., Bristol Myers Squibb, GlaxoSmithKline, Pfizer, Sanofi, Takeda, AstraZeneca, Bayer, Eli Lilly & Co., Gilead Sciences, Amgen, Novo Nordisk, Teva, Boehringer Ingelheim, Biogen, Astellas
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Format, by Prescription, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pharma and Health Care companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Format, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Prescription, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Pharma and Health Care Market growing?

Ans: The Pharma and Health Care Market witnessing a CAGR of 4.0% during the forecast period 2024-2030.

What is the Pharma and Health Care Market size in 2030?

Ans: The Pharma and Health Care Market size in 2030 will be US$ 1644850 million.

What is the Pharma and Health Care Market share by region?

Ans: North America is the largest consumption place, with a consumption market share nearly 50%.

Who are the main players in the Pharma and Health Care Market report?

Ans: The main players in the Pharma and Health Care Market are Johnson & Johnson, Novartis, Roche, AbbVie, Merck & Co., Bristol Myers Squibb, GlaxoSmithKline, Pfizer, Sanofi, Takeda, AstraZeneca, Bayer, Eli Lilly & Co., Gilead Sciences, Amgen, Novo Nordisk, Teva, Boehringer Ingelheim, Biogen, Astellas

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Format

1.2.1 Global Pharma and Health Care Market Size Growth Rate by Format: 2019 VS 2023 VS 2030

1.2.2 Bottle

1.2.3 Blister

1.2.4 Others

1.3 Market by Prescription

1.3.1 Global Pharma and Health Care Market Growth by Prescription: 2019 VS 2023 VS 2030

1.3.2 OTC Drugs

1.3.3 Prescription Drugs

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Pharma and Health Care Market Perspective (2019-2030)

2.2 Pharma and Health Care Growth Trends by Region

2.2.1 Global Pharma and Health Care Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Pharma and Health Care Historic Market Size by Region (2019-2024)

2.2.3 Pharma and Health Care Forecasted Market Size by Region (2025-2030)

2.3 Pharma and Health Care Market Dynamics

2.3.1 Pharma and Health Care Industry Trends

2.3.2 Pharma and Health Care Market Drivers

2.3.3 Pharma and Health Care Market Challenges

2.3.4 Pharma and Health Care Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Pharma and Health Care Players by Revenue

3.1.1 Global Top Pharma and Health Care Players by Revenue (2019-2024)

3.1.2 Global Pharma and Health Care Revenue Market Share by Players (2019-2024)

3.2 Global Pharma and Health Care Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Pharma and Health Care Revenue

3.4 Global Pharma and Health Care Market Concentration Ratio

3.4.1 Global Pharma and Health Care Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Pharma and Health Care Revenue in 2023

3.5 Pharma and Health Care Key Players Head office and Area Served

3.6 Key Players Pharma and Health Care Product Solution and Service

3.7 Date of Enter into Pharma and Health Care Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Pharma and Health Care Breakdown Data by Format

4.1 Global Pharma and Health Care Historic Market Size by Format (2019-2024)

4.2 Global Pharma and Health Care Forecasted Market Size by Format (2025-2030)

5 Pharma and Health Care Breakdown Data by Prescription

5.1 Global Pharma and Health Care Historic Market Size by Prescription (2019-2024)

5.2 Global Pharma and Health Care Forecasted Market Size by Prescription (2025-2030)

6 North America

6.1 North America Pharma and Health Care Market Size (2019-2030)

6.2 North America Pharma and Health Care Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Pharma and Health Care Market Size by Country (2019-2024)

6.4 North America Pharma and Health Care Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Pharma and Health Care Market Size (2019-2030)

7.2 Europe Pharma and Health Care Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Pharma and Health Care Market Size by Country (2019-2024)

7.4 Europe Pharma and Health Care Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Pharma and Health Care Market Size (2019-2030)

8.2 Asia-Pacific Pharma and Health Care Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Pharma and Health Care Market Size by Region (2019-2024)

8.4 Asia-Pacific Pharma and Health Care Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Pharma and Health Care Market Size (2019-2030)

9.2 Latin America Pharma and Health Care Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Pharma and Health Care Market Size by Country (2019-2024)

9.4 Latin America Pharma and Health Care Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Pharma and Health Care Market Size (2019-2030)

10.2 Middle East & Africa Pharma and Health Care Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Pharma and Health Care Market Size by Country (2019-2024)

10.4 Middle East & Africa Pharma and Health Care Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Johnson & Johnson

11.1.1 Johnson & Johnson Company Detail

11.1.2 Johnson & Johnson Business Overview

11.1.3 Johnson & Johnson Pharma and Health Care Introduction

11.1.4 Johnson & Johnson Revenue in Pharma and Health Care Business (2019-2024)

11.1.5 Johnson & Johnson Recent Development

11.2 Novartis

11.2.1 Novartis Company Detail

11.2.2 Novartis Business Overview

11.2.3 Novartis Pharma and Health Care Introduction

11.2.4 Novartis Revenue in Pharma and Health Care Business (2019-2024)

11.2.5 Novartis Recent Development

11.3 Roche

11.3.1 Roche Company Detail

11.3.2 Roche Business Overview

11.3.3 Roche Pharma and Health Care Introduction

11.3.4 Roche Revenue in Pharma and Health Care Business (2019-2024)

11.3.5 Roche Recent Development

11.4 AbbVie

11.4.1 AbbVie Company Detail

11.4.2 AbbVie Business Overview

11.4.3 AbbVie Pharma and Health Care Introduction

11.4.4 AbbVie Revenue in Pharma and Health Care Business (2019-2024)

11.4.5 AbbVie Recent Development

11.5 Merck & Co.

11.5.1 Merck & Co. Company Detail

11.5.2 Merck & Co. Business Overview

11.5.3 Merck & Co. Pharma and Health Care Introduction

11.5.4 Merck & Co. Revenue in Pharma and Health Care Business (2019-2024)

11.5.5 Merck & Co. Recent Development

11.6 Bristol Myers Squibb

11.6.1 Bristol Myers Squibb Company Detail

11.6.2 Bristol Myers Squibb Business Overview

11.6.3 Bristol Myers Squibb Pharma and Health Care Introduction

11.6.4 Bristol Myers Squibb Revenue in Pharma and Health Care Business (2019-2024)

11.6.5 Bristol Myers Squibb Recent Development

11.7 GlaxoSmithKline

11.7.1 GlaxoSmithKline Company Detail

11.7.2 GlaxoSmithKline Business Overview

11.7.3 GlaxoSmithKline Pharma and Health Care Introduction

11.7.4 GlaxoSmithKline Revenue in Pharma and Health Care Business (2019-2024)

11.7.5 GlaxoSmithKline Recent Development

11.8 Pfizer

11.8.1 Pfizer Company Detail

11.8.2 Pfizer Business Overview

11.8.3 Pfizer Pharma and Health Care Introduction

11.8.4 Pfizer Revenue in Pharma and Health Care Business (2019-2024)

11.8.5 Pfizer Recent Development

11.9 Sanofi

11.9.1 Sanofi Company Detail

11.9.2 Sanofi Business Overview

11.9.3 Sanofi Pharma and Health Care Introduction

11.9.4 Sanofi Revenue in Pharma and Health Care Business (2019-2024)

11.9.5 Sanofi Recent Development

11.10 Takeda

11.10.1 Takeda Company Detail

11.10.2 Takeda Business Overview

11.10.3 Takeda Pharma and Health Care Introduction

11.10.4 Takeda Revenue in Pharma and Health Care Business (2019-2024)

11.10.5 Takeda Recent Development

11.11 AstraZeneca

11.11.1 AstraZeneca Company Detail

11.11.2 AstraZeneca Business Overview

11.11.3 AstraZeneca Pharma and Health Care Introduction

11.11.4 AstraZeneca Revenue in Pharma and Health Care Business (2019-2024)

11.11.5 AstraZeneca Recent Development

11.12 Bayer

11.12.1 Bayer Company Detail

11.12.2 Bayer Business Overview

11.12.3 Bayer Pharma and Health Care Introduction

11.12.4 Bayer Revenue in Pharma and Health Care Business (2019-2024)

11.12.5 Bayer Recent Development

11.13 Eli Lilly & Co.

11.13.1 Eli Lilly & Co. Company Detail

11.13.2 Eli Lilly & Co. Business Overview

11.13.3 Eli Lilly & Co. Pharma and Health Care Introduction

11.13.4 Eli Lilly & Co. Revenue in Pharma and Health Care Business (2019-2024)

11.13.5 Eli Lilly & Co. Recent Development

11.14 Gilead Sciences

11.14.1 Gilead Sciences Company Detail

11.14.2 Gilead Sciences Business Overview

11.14.3 Gilead Sciences Pharma and Health Care Introduction

11.14.4 Gilead Sciences Revenue in Pharma and Health Care Business (2019-2024)

11.14.5 Gilead Sciences Recent Development

11.15 Amgen

11.15.1 Amgen Company Detail

11.15.2 Amgen Business Overview

11.15.3 Amgen Pharma and Health Care Introduction

11.15.4 Amgen Revenue in Pharma and Health Care Business (2019-2024)

11.15.5 Amgen Recent Development

11.16 Novo Nordisk

11.16.1 Novo Nordisk Company Detail

11.16.2 Novo Nordisk Business Overview

11.16.3 Novo Nordisk Pharma and Health Care Introduction

11.16.4 Novo Nordisk Revenue in Pharma and Health Care Business (2019-2024)

11.16.5 Novo Nordisk Recent Development

11.17 Teva

11.17.1 Teva Company Detail

11.17.2 Teva Business Overview

11.17.3 Teva Pharma and Health Care Introduction

11.17.4 Teva Revenue in Pharma and Health Care Business (2019-2024)

11.17.5 Teva Recent Development

11.18 Boehringer Ingelheim

11.18.1 Boehringer Ingelheim Company Detail

11.18.2 Boehringer Ingelheim Business Overview

11.18.3 Boehringer Ingelheim Pharma and Health Care Introduction

11.18.4 Boehringer Ingelheim Revenue in Pharma and Health Care Business (2019-2024)

11.18.5 Boehringer Ingelheim Recent Development

11.19 Biogen

11.19.1 Biogen Company Detail

11.19.2 Biogen Business Overview

11.19.3 Biogen Pharma and Health Care Introduction

11.19.4 Biogen Revenue in Pharma and Health Care Business (2019-2024)

11.19.5 Biogen Recent Development

11.20 Astellas

11.20.1 Astellas Company Detail

11.20.2 Astellas Business Overview

11.20.3 Astellas Pharma and Health Care Introduction

11.20.4 Astellas Revenue in Pharma and Health Care Business (2019-2024)

11.20.5 Astellas Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Johnson & Johnson

Novartis

Roche

AbbVie

Merck

Bristol–Myers Squibb

GlaxoSmithKline PLC

Pfizer Inc

Sanofi

Takeda

Astrazeneca plc

Bayer

Eli Lilly & Co

Gilead Sciences

Amgen Inc

Novo Nordisk

TEVA

Boehringer Ingelheim

Biogen

Astellas

List of Tables

Table 1. Global Pharma and Health Care Market Size Growth Rate by Format (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Bottle

Table 3. Key Players of Blister

Table 4. Key Players of Others

Table 5. Global Pharma and Health Care Market Size Growth by Prescription (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Pharma and Health Care Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global Pharma and Health Care Market Size by Region (2019-2024) & (US$ Million)

Table 8. Global Pharma and Health Care Market Share by Region (2019-2024)

Table 9. Global Pharma and Health Care Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 10. Global Pharma and Health Care Market Share by Region (2025-2030)

Table 11. Pharma and Health Care Market Trends

Table 12. Pharma and Health Care Market Drivers

Table 13. Pharma and Health Care Market Challenges

Table 14. Pharma and Health Care Market Restraints

Table 15. Global Pharma and Health Care Revenue by Players (2019-2024) & (US$ Million)

Table 16. Global Pharma and Health Care Market Share by Players (2019-2024)

Table 17. Global Top Pharma and Health Care Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharma and Health Care as of 2023)

Table 18. Ranking of Global Top Pharma and Health Care Companies by Revenue (US$ Million) in 2023

Table 19. Global 5 Largest Players Market Share by Pharma and Health Care Revenue (CR5 and HHI) & (2019-2024)

Table 20. Key Players Headquarters and Area Served

Table 21. Key Players Pharma and Health Care Product Solution and Service

Table 22. Date of Enter into Pharma and Health Care Market

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Pharma and Health Care Market Size by Format (2019-2024) & (US$ Million)

Table 25. Global Pharma and Health Care Revenue Market Share by Format (2019-2024)

Table 26. Global Pharma and Health Care Forecasted Market Size by Format (2025-2030) & (US$ Million)

Table 27. Global Pharma and Health Care Revenue Market Share by Format (2025-2030)

Table 28. Global Pharma and Health Care Market Size by Prescription (2019-2024) & (US$ Million)

Table 29. Global Pharma and Health Care Revenue Market Share by Prescription (2019-2024)

Table 30. Global Pharma and Health Care Forecasted Market Size by Prescription (2025-2030) & (US$ Million)

Table 31. Global Pharma and Health Care Revenue Market Share by Prescription (2025-2030)

Table 32. North America Pharma and Health Care Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 33. North America Pharma and Health Care Market Size by Country (2019-2024) & (US$ Million)

Table 34. North America Pharma and Health Care Market Size by Country (2025-2030) & (US$ Million)

Table 35. Europe Pharma and Health Care Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 36. Europe Pharma and Health Care Market Size by Country (2019-2024) & (US$ Million)

Table 37. Europe Pharma and Health Care Market Size by Country (2025-2030) & (US$ Million)

Table 38. Asia-Pacific Pharma and Health Care Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 39. Asia-Pacific Pharma and Health Care Market Size by Region (2019-2024) & (US$ Million)

Table 40. Asia-Pacific Pharma and Health Care Market Size by Region (2025-2030) & (US$ Million)

Table 41. Latin America Pharma and Health Care Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 42. Latin America Pharma and Health Care Market Size by Country (2019-2024) & (US$ Million)

Table 43. Latin America Pharma and Health Care Market Size by Country (2025-2030) & (US$ Million)

Table 44. Middle East & Africa Pharma and Health Care Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 45. Middle East & Africa Pharma and Health Care Market Size by Country (2019-2024) & (US$ Million)

Table 46. Middle East & Africa Pharma and Health Care Market Size by Country (2025-2030) & (US$ Million)

Table 47. Johnson & Johnson Company Detail

Table 48. Johnson & Johnson Business Overview

Table 49. Johnson & Johnson Pharma and Health Care Product

Table 50. Johnson & Johnson Revenue in Pharma and Health Care Business (2019-2024) & (US$ Million)

Table 51. Johnson & Johnson Recent Development

Table 52. Novartis Company Detail

Table 53. Novartis Business Overview

Table 54. Novartis Pharma and Health Care Product

Table 55. Novartis Revenue in Pharma and Health Care Business (2019-2024) & (US$ Million)

Table 56. Novartis Recent Development

Table 57. Roche Company Detail

Table 58. Roche Business Overview

Table 59. Roche Pharma and Health Care Product

Table 60. Roche Revenue in Pharma and Health Care Business (2019-2024) & (US$ Million)

Table 61. Roche Recent Development

Table 62. AbbVie Company Detail

Table 63. AbbVie Business Overview

Table 64. AbbVie Pharma and Health Care Product

Table 65. AbbVie Revenue in Pharma and Health Care Business (2019-2024) & (US$ Million)

Table 66. AbbVie Recent Development

Table 67. Merck & Co. Company Detail

Table 68. Merck & Co. Business Overview

Table 69. Merck & Co. Pharma and Health Care Product

Table 70. Merck & Co. Revenue in Pharma and Health Care Business (2019-2024) & (US$ Million)

Table 71. Merck & Co. Recent Development

Table 72. Bristol Myers Squibb Company Detail

Table 73. Bristol Myers Squibb Business Overview

Table 74. Bristol Myers Squibb Pharma and Health Care Product

Table 75. Bristol Myers Squibb Revenue in Pharma and Health Care Business (2019-2024) & (US$ Million)

Table 76. Bristol Myers Squibb Recent Development

Table 77. GlaxoSmithKline Company Detail

Table 78. GlaxoSmithKline Business Overview

Table 79. GlaxoSmithKline Pharma and Health Care Product

Table 80. GlaxoSmithKline Revenue in Pharma and Health Care Business (2019-2024) & (US$ Million)

Table 81. GlaxoSmithKline Recent Development

Table 82. Pfizer Company Detail

Table 83. Pfizer Business Overview

Table 84. Pfizer Pharma and Health Care Product

Table 85. Pfizer Revenue in Pharma and Health Care Business (2019-2024) & (US$ Million)

Table 86. Pfizer Recent Development

Table 87. Sanofi Company Detail

Table 88. Sanofi Business Overview

Table 89. Sanofi Pharma and Health Care Product

Table 90. Sanofi Revenue in Pharma and Health Care Business (2019-2024) & (US$ Million)

Table 91. Sanofi Recent Development

Table 92. Takeda Company Detail

Table 93. Takeda Business Overview

Table 94. Takeda Pharma and Health Care Product

Table 95. Takeda Revenue in Pharma and Health Care Business (2019-2024) & (US$ Million)

Table 96. Takeda Recent Development

Table 97. AstraZeneca Company Detail

Table 98. AstraZeneca Business Overview

Table 99. AstraZeneca Pharma and Health Care Product

Table 100. AstraZeneca Revenue in Pharma and Health Care Business (2019-2024) & (US$ Million)

Table 101. AstraZeneca Recent Development

Table 102. Bayer Company Detail

Table 103. Bayer Business Overview

Table 104. Bayer Pharma and Health Care Product

Table 105. Bayer Revenue in Pharma and Health Care Business (2019-2024) & (US$ Million)

Table 106. Bayer Recent Development

Table 107. Eli Lilly & Co. Company Detail

Table 108. Eli Lilly & Co. Business Overview

Table 109. Eli Lilly & Co. Pharma and Health Care Product

Table 110. Eli Lilly & Co. Revenue in Pharma and Health Care Business (2019-2024) & (US$ Million)

Table 111. Eli Lilly & Co. Recent Development

Table 112. Gilead Sciences Company Detail

Table 113. Gilead Sciences Business Overview

Table 114. Gilead Sciences Pharma and Health Care Product

Table 115. Gilead Sciences Revenue in Pharma and Health Care Business (2019-2024) & (US$ Million)

Table 116. Gilead Sciences Recent Development

Table 117. Amgen Company Detail

Table 118. Amgen Business Overview

Table 119. Amgen Pharma and Health Care Product

Table 120. Amgen Revenue in Pharma and Health Care Business (2019-2024) & (US$ Million)

Table 121. Amgen Recent Development

Table 122. Novo Nordisk Company Detail

Table 123. Novo Nordisk Business Overview

Table 124. Novo Nordisk Pharma and Health Care Product

Table 125. Novo Nordisk Revenue in Pharma and Health Care Business (2019-2024) & (US$ Million)

Table 126. Novo Nordisk Recent Development

Table 127. Teva Company Detail

Table 128. Teva Business Overview

Table 129. Teva Pharma and Health Care Product

Table 130. Teva Revenue in Pharma and Health Care Business (2019-2024) & (US$ Million)

Table 131. Teva Recent Development

Table 132. Boehringer Ingelheim Company Detail

Table 133. Boehringer Ingelheim Business Overview

Table 134. Boehringer Ingelheim Pharma and Health Care Product

Table 135. Boehringer Ingelheim Revenue in Pharma and Health Care Business (2019-2024) & (US$ Million)

Table 136. Boehringer Ingelheim Recent Development

Table 137. Biogen Company Detail

Table 138. Biogen Business Overview

Table 139. Biogen Pharma and Health Care Product

Table 140. Biogen Revenue in Pharma and Health Care Business (2019-2024) & (US$ Million)

Table 141. Biogen Recent Development

Table 142. Astellas Company Detail

Table 143. Astellas Business Overview

Table 144. Astellas Pharma and Health Care Product

Table 145. Astellas Revenue in Pharma and Health Care Business (2019-2024) & (US$ Million)

Table 146. Astellas Recent Development

Table 147. Research Programs/Design for This Report

Table 148. Key Data Information from Secondary Sources

Table 149. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Pharma and Health Care Market Size Comparison by Format (2024-2030) & (US$ Million)

Figure 2. Global Pharma and Health Care Market Share by Format: 2023 VS 2030

Figure 3. Bottle Features

Figure 4. Blister Features

Figure 5. Others Features

Figure 6. Global Pharma and Health Care Market Size Comparison by Prescription (2024-2030) & (US$ Million)

Figure 7. Global Pharma and Health Care Market Share by Prescription: 2023 VS 2030

Figure 8. OTC Drugs Case Studies

Figure 9. Prescription Drugs Case Studies

Figure 10. Pharma and Health Care Report Years Considered

Figure 11. Global Pharma and Health Care Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 12. Global Pharma and Health Care Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 13. Global Pharma and Health Care Market Share by Region: 2023 VS 2030

Figure 14. Global Pharma and Health Care Market Share by Players in 2023

Figure 15. Global Top Pharma and Health Care Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharma and Health Care as of 2023)

Figure 16. The Top 10 and 5 Players Market Share by Pharma and Health Care Revenue in 2023

Figure 17. North America Pharma and Health Care Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 18. North America Pharma and Health Care Market Share by Country (2019-2030)

Figure 19. United States Pharma and Health Care Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. Canada Pharma and Health Care Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. Europe Pharma and Health Care Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Europe Pharma and Health Care Market Share by Country (2019-2030)

Figure 23. Germany Pharma and Health Care Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. France Pharma and Health Care Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. U.K. Pharma and Health Care Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. Italy Pharma and Health Care Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Russia Pharma and Health Care Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Nordic Countries Pharma and Health Care Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Asia-Pacific Pharma and Health Care Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Asia-Pacific Pharma and Health Care Market Share by Region (2019-2030)

Figure 31. China Pharma and Health Care Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Japan Pharma and Health Care Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. South Korea Pharma and Health Care Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Southeast Asia Pharma and Health Care Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. India Pharma and Health Care Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Australia Pharma and Health Care Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Latin America Pharma and Health Care Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Latin America Pharma and Health Care Market Share by Country (2019-2030)

Figure 39. Mexico Pharma and Health Care Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Brazil Pharma and Health Care Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Middle East & Africa Pharma and Health Care Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Middle East & Africa Pharma and Health Care Market Share by Country (2019-2030)

Figure 43. Turkey Pharma and Health Care Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Saudi Arabia Pharma and Health Care Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Johnson & Johnson Revenue Growth Rate in Pharma and Health Care Business (2019-2024)

Figure 46. Novartis Revenue Growth Rate in Pharma and Health Care Business (2019-2024)

Figure 47. Roche Revenue Growth Rate in Pharma and Health Care Business (2019-2024)

Figure 48. AbbVie Revenue Growth Rate in Pharma and Health Care Business (2019-2024)

Figure 49. Merck & Co. Revenue Growth Rate in Pharma and Health Care Business (2019-2024)

Figure 50. Bristol Myers Squibb Revenue Growth Rate in Pharma and Health Care Business (2019-2024)

Figure 51. GlaxoSmithKline Revenue Growth Rate in Pharma and Health Care Business (2019-2024)

Figure 52. Pfizer Revenue Growth Rate in Pharma and Health Care Business (2019-2024)

Figure 53. Sanofi Revenue Growth Rate in Pharma and Health Care Business (2019-2024)

Figure 54. Takeda Revenue Growth Rate in Pharma and Health Care Business (2019-2024)

Figure 55. AstraZeneca Revenue Growth Rate in Pharma and Health Care Business (2019-2024)

Figure 56. Bayer Revenue Growth Rate in Pharma and Health Care Business (2019-2024)

Figure 57. Eli Lilly & Co. Revenue Growth Rate in Pharma and Health Care Business (2019-2024)

Figure 58. Gilead Sciences Revenue Growth Rate in Pharma and Health Care Business (2019-2024)

Figure 59. Amgen Revenue Growth Rate in Pharma and Health Care Business (2019-2024)

Figure 60. Novo Nordisk Revenue Growth Rate in Pharma and Health Care Business (2019-2024)

Figure 61. Teva Revenue Growth Rate in Pharma and Health Care Business (2019-2024)

Figure 62. Boehringer Ingelheim Revenue Growth Rate in Pharma and Health Care Business (2019-2024)

Figure 63. Biogen Revenue Growth Rate in Pharma and Health Care Business (2019-2024)

Figure 64. Astellas Revenue Growth Rate in Pharma and Health Care Business (2019-2024)

Figure 65. Bottom-up and Top-down Approaches for This Report

Figure 66. Data Triangulation

Figure 67. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Substrate Cutting Device Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-23Z18292

Thu Dec 12 00:00:00 UTC 2024

Add to Cart

Targeted Radionuclide Drug - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-14Z15017

Thu Dec 12 00:00:00 UTC 2024

Add to Cart

Global Microfluidic Single-Cell Analysis and Screening System Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-7M18883

Thu Dec 12 00:00:00 UTC 2024

Add to Cart

Medicinal Liquid Filling Equipment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-37J14968

Thu Dec 12 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions